Peer-reviewed articles

Ladanchuk TC, Johnston BT, Murray LJ, Anderson LA, FINBAR study group. Risk of Barrett’s oesophagus, oesophageal adenocarcinoma and reflux oesophagitis and the use of nitrates and asthma medications. Scand J Gastroenterol. 2010;45(12):1397-1403. doi:10.3109/00365521.2010.503968

Sant M, Allemani C, Tereanu C, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 2010;116(19):3724-3734. doi:10.1182/blood-2010-05-282632

Sharp L, Foll P, Deady S, O’Ceilleachair A, Buicke C, Carsin AE. Where do people with lung cancer die and how is this changing? A population-based study. Ir Med J. 2010;103(9):262-264, 266.

Murphy SJ, Anderson LA, Ferguson HR, et al. Dietary antioxidant and mineral intake in humans is associated with reduced risk of esophageal adenocarcinoma but not reflux esophagitis or Barrett’s esophagus. J Nutr. 2010;140(10):1757-1763. doi:10.3945/jn.110.124362

Cook MB, Kamangar F, Whiteman DC, et al. Cigarette Smoking and Adenocarcinomas of the Esophagus and Esophagogastric Junction: A Pooled Analysis From the International BEACON Consortium. J Natl Cancer Inst. 2010;102(17):1344-1353. doi:10.1093/jnci/djq289

Carsin AE, Drummond FJ, Black A, et al. Impact of PSA testing and prostatic biopsy on cancer incidence and mortality: comparative study between the Republic of Ireland and Northern Ireland. Cancer Causes Control. 2010;21(9):1523-1531. doi:10.1007/s10552-010-9581-y

Hegarty AC, Carsin AE, Comber H. Geographical analysis of cancer incidence in Ireland: a comparison of two Bayesian spatial models. Cancer Epidemiol. 2010;34(4):373-381. doi:10.1016/j.canep.2010.04.019

HAEMACARE Working Group. Manual for coding and reporting haematological malignancies. Tumori. 2010;96(4):i-A32.

on behalf of the EUROCHIP Working Group, Viberga I, Engele L, Baili P. Past, Present and Future of the Cervical Cancer Screening in Latvia. Tumori. 2010;96(4):529-537. doi:10.1177/030089161009600404

on behalf of the EUROCHIP Working Group, Veerus P, Arbyn M, Amati C, Baili P. Impact of Implementing a Nationwide Cervical Cancer Screening Program on Female Population Coverage by Pap-Tests in Estonia. Tumori. 2010;96(4):524-528. doi:10.1177/030089161009600403

on behalf of the EUROCHIP Working Group, Valerianova Z, Panayotova Y, Amati C, Baili P. Cervical Cancer Screening in Bulgaria - past and Present Experience. Tumori. 2010;96(4):538-544. doi:10.1177/030089161009600405

on behalf of the EUROCHIP Working Group, Apostol I, Baban A, et al. Cervical Cancer Assessment in Romania under EUROCHIP-2. Tumori. 2010;96(4):545-552. doi:10.1177/030089161009600406

Doherty G, Walsh P, Sheridan J, et al. Clinical and pathological factors associated with colorectal cancer at the upper extreme of life. J Am Geriatr Soc. 2010;58(4):794-795. doi:10.1111/j.1532-5415.2010.02793.x

Drummond FJ, Carsin AE, Sharp L, Comber H. Trends in prostate specific antigen testing in Ireland: lessons from a country without guidelines. Ir J Med Sci. 2010;179(1):43-49. doi:10.1007/s11845-009-0376-7

Field S, Deady S, Fitzgibbon J, Murphy M, Comber H. Improved malignant melanoma prognosis at a consultant-delivered multidisciplinary pigmented lesion clinic in Cork. Ir Med J. 2010;103(2):40-43.

Woods LM, Rachet B, Shack L, et al. Survival from twenty adult cancers in the UK and Republic of Ireland in the late twentieth century. Health Stat Q. 2010;(46):5-24. doi:10.1057/hsq.2010.9

Hegarty J, Beirne PV, Walsh E, Comber H, Fitzgerald T, Wallace Kazer M. Radical prostatectomy versus watchful waiting for prostate cancer. Cochrane Database SystRev. 2010;(11)(11):CD006590. doi:10.1002/14651858.CD006590.pub2

Kerner JF, Cazap E, Yach D, et al. Comprehensive cancer control-research & development: knowing what we do and doing what we know. Tumori. 2009;95(5):610-622. doi:10.1177/030089160909500504

Sharp L, Carsin AE, Cronin-Fenton DP, O’Driscoll D, Comber H. Is there under-treatment of pancreatic cancer? Evidence from a population-based study in Ireland. Eur J Cancer. 2009;45(8):1450-1459. doi:10.1016/j.ejca.2009.01.033

Verdecchia A, Guzzinati S, Francisci S, et al. Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer. 2009;45:1042-1066. doi:10.1016/j.ejca.2008.11.029

Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer. 2009;45(6):931-991. doi:10.1016/j.ejca.2008.11.018

Rosso S, De Angelis R, Ciccolallo L, et al. Multiple tumours in survival estimates. European Journal of Cancer. 2009;45(6):1080-1094. doi:10.1016/j.ejca.2008.11.030

Quaglia A, Tavilla A, Shack L, et al. The cancer survival gap between elderly and middle-aged patients in Europe is widening. European Journal of Cancer. 2009;45(6):1006-1016. doi:10.1016/j.ejca.2008.11.028

Mulholland HG, Cantwell MM, Anderson LA, et al. Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett’s esophagus, and esophageal adenocarcinoma. Cancer Causes Control. 2009;20(3):279-288. doi:10.1007/s10552-008-9242-6

Gatta G, Zigon G, Capocaccia R, et al. Survival of European children and young adults with cancer diagnosed 1995–2002. European Journal of Cancer. 2009;45(6):992-1005. doi:10.1016/j.ejca.2008.11.042